FDA
-
-
-
-
-
-
-
Elutia adds medical technology veteran Neels to board of directors
-
-
-
-
-
-
-
Elutia to exhibit EluPro at Vizient technology exchange
-
-
-
-
-
-
-
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
-
-
-
-
-
-
-
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
-
-
-
-
-
-
-
Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners
-
-
-
-
-
-
-
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
-
-
-
-
-
-
-
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

